B J A Poynter01031 December 202425.0023.5001 January 20240163419900991100100266956207632138600155041138600155041148867753061161114886775306116115807669265119393647602030654302587195635959351849767342310850137232212720714144287116197363679131397467950011696236968741136302810010010010010010010010010010010010010010010010010010010010065563655636556365563173631736371457145102181021827409274094234423423175231759003321783730787010395215657826053017839149594167433123966126173657544388333937761217913061724279632631526315954763061724016488410011841844474970182012625752612556347735693744626405527594522376372242956Critical judgments in applying the Group's accounting policies In the application of the Group’s accounting policies, which are described in note 2, the directors are required to make judgements (other than those involving estimations) that have a significant impact on the amounts recognised and to make estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The following are the critical judgements, apart from those involving estimations (which are dealt with separately below), that the directors have made in the process of applying the Group’s accounting policies and that have the most significant effect on the amounts recognised in the financial statements. In preparing these financial statements, the Directors have made the following judgments: Going concernAs disclosed in Note 2c Going concern the directors have judged that there is a reasonable expectation that the Company and the Group will be able to continue as a going concern for the foreseeable future. In coming to this conclusion, they judged that the Company and the Group's shareholder and lender will be willing to provide the necessary financial support. However, as there is no legal obligation on the shareholder and the lender to provide this financial support, the directors have had to use judgment to conclude that the Group and the Company are going concerns. This judgement is pervasive to the financial statements. Shellco business transfer During the year, administrators were appointed to Shellco 2021 Limited, and with the approval of Northwall Capital as the main creditor (and owner of Olsam OpCo) the Shellco 2021 Limited business and related assets were transferred to Personal Grooming Co Limited on 24 October 2024. The directors exercised judgement in determining the appropriate accounting treatment for this transaction, as FRS 102 does not prescribe a specific accounting treatment for business transfers between entities under common control. The directors considered whether the transaction should be accounted for as an asset acquisition, a business combination, or a common-control business transfer. In making this assessment, the directors considered the continuity of ultimate ownership, the continuation of the underlying business, the transfer of the related assets and trading operations, and the fact that the consideration was satisfied through the release of guarantee claims rather than cash consideration. The directors concluded that the transaction represented a transfer of a business between entities under common ultimate control. Accordingly, predecessor accounting was applied, with the transferred assets and liabilities recognised at their existing carrying amounts immediately before the transfer. No fair value uplift, new goodwill or bargain purchase gain was recognised. The gain on disposal arises solely from the net obligations that were avoided as a result of the administration. This is disclosed as “Profit arising on the disposal of a subsidiary” on the face of the Consolidated Statement of Comprehensive Income.  Impairment assessmentsDue to the losses incurred and the Group’s continued trading challenges during the year, the directors considered whether there were indicators of impairment in respect of the Group’s goodwill, trademarks, software and investments. The directors identified that the appropriate cash-generating units remained aligned with the trading names and brands used by the Group in its marketplace and direct-to-consumer operations. In undertaking the assessments, the directors considered the carrying value of the relevant assets by cash-generating unit, including the associated goodwill and trademarks, and compared these amounts with the estimated recoverable amount of each cash-generating unit. The recoverable amount was assessed by reference to the expected future cash flows and trading prospects of the relevant brands, taking account of the 2024, 2025 and 2026 trading performance, stock and supply-chain challenges, the macroeconomic environment and the restructuring completed during the year. Following this assessment, the directors recognised an impairment charge of £0.7 million (2023: £38 million) in the year ended 31 December 2024, comprising £0.3 million (2023: £29.7 million) in respect of goodwill and £0.4 million (2023: £8.3 million) in respect of trademarks. No impairment was recognised in respect of software or investments. The impairment charge principally related to the Bro Shaver and Wanderlust Products Limited, trading as D&D cash-generating units, where the directors considered that the carrying value of the related goodwill and trademarks was no longer fully supported by expected future performance. After recognising the impairment charge and amortisation for the year, the Group’s carrying value of goodwill at 31 December 2024 was £3.3 million (2023: £4.1 million) and the carrying value of trademarks was £6.0 million (2023: £7.2 million) (Note 12). The directors consider that the remaining carrying values are supported by the expected future trading performance of the relevant cash-generating units.  Amendments to loan agreementsThe Company entered into a loan agreement in 2021, which was amended in 2022 and 2023, and during 2024 the loan arrangements were further amended and restated. In addition, on 24 October 2024, a Partial Deed of Release was entered into under which part of the outstanding debt was released and discharged.The directors considered whether the 2024 amendments to the loan arrangements represented a substantial modification of the existing financial liabilities and hence whether the existing loans should be derecognised and new financial liabilities recognised. On derecognition of a loan, any loan transaction costs relating to the original loan agreement which have yet to be expensed are written off and any costs associated with the amendment are spread over the amended loan term using the effective interest rate method.The directors assessed that the amendments to the loan arrangements were not substantial modifications and therefore the original loan transaction costs continue to be expensed over the life of the loan. Loan amendment fees were expensed as incurred.The element of the outstanding loan balance released during the year was derecognised when the Company was legally released from its obligation to repay that amount. As the release was made in the lender’s capacity as an owner, the amount released was recognised as a capital contribution directly in equity. Loan extensions The loan agreements include an option for the lender to extend the loan repayment date from 31 December 2025 to 31 December 2026. NorthWall Capital advised during the year that the loans had been extended. This has been documented in the letter of support provided by NorthWall Capital. The directors have prepared these financial statements on the basis that the loans have been extended, based on the statements made by NorthWall Capital, the written confirmation of the extension subsequently received and the fact that repayment of the loans was not demanded on 31 December 2025. Amounts owed to/from Group undertakingsAccounting for amounts receivable and payable from Olsam Group Limited following the liquidation of Olsam Group Limited. All payables relating to this entity were released and hence credited directly to equity in accordance with FRS 102 as this credit was received whilst Olsam Group was an equity participant in Olsam Opco Limited. However, since there was no formal agreement in respect to receivables, and hence no formal right to offset, the £1.3 million impairment of these balances has been charged to profit or loss rather than being offset with the capital contribution arising on the release of the payables which was credited directly to equity.  Waiver of cash interestWaiver of cash interest under the loan agreements interest is due via payments in kind notes, together with a smaller cash element. Immediately following the restructure, Northwall Capital advised that they will not seek to collect the cash element of the interest. As this is contractually due under the loan agreements, which have not been amended in this regard, the directors continue to accrue the interest and then release the accruals as capital contributions. (See note 18). Valuation of investmentsAssets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below. Non-financial assets An asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use. The recoverable amount of goodwill is derived from an estimate of the present value of the future cash flows of the cash-generating units of which the goodwill is a part. Any impairment loss in respect of a CGU is allocated first to the goodwill attached to that CGU, and then to other assets within that CGU on a pro-rata basis. Where indicators exist for a decrease in impairment loss previously recognised for assets other than goodwill, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised. Where a reversal of impairment occurs in respect of a CGU, the reversal is applied to the assets of the CGU, except for goodwill, on a pro-rata basis. Impairment of goodwill is never reversed.  Financial assetsFor financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate. For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date. Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.Exceptional itemsThe financial statements have been prepared using the going concern basis of accounting.The Company and the Group have historically relied upon external funding to maintain an adequate level of liquidity to support their ongoing operations and growth. During 2024, the Group’s trading performance was affected by the integration of the Dwarfs B.V. business, which was acquired in late December 2023, stock challenges associated with that business and the challenging macroeconomic environment.Following discussions between the major equity holders of the then parent company, Olsam Group Limited, and the Group’s debt providers, the Group underwent a restructuring in August 2024. As part of the restructuring, control of Olsam OpCo Limited and its subsidiaries passed to a new parent company, Fairweather BidCo Limited, which is owned by funds managed by NorthWall Capital. Following the restructuring, the Group received a significant injection of capital to fund its existing operations and support further brand acquisitions. Certain loans were also waived, significantly reducing the level of debt within the Group.Since the restructuring, further financial support has been provided to the Group, including funding for the acquisition of the Wrinkles Schminkles business in July 2025 and associated acquisition payments during 2026. In line with the plans established at the time of the restructuring, a further reduction in the debt held within the Group is expected to take place during the third quarter of 2026.The Company and the Group remain reliant on continued capital contributions and financial support in the near term, although at a significantly reduced level following the capital injection and loan waivers completed as part of the restructuring. The directors expect this reliance to reduce further as the benefits of the restructuring, the strategic reset of the business and the actions taken to improve trading performance and cash generation are realised.The directors have reviewed the Company’s and the Group’s forecasts and cash flow projections to 31 December 2028. These forecasts reflect expected trading performance, working capital requirements, operating and financing costs, the capital provided following the restructuring, the waiver and anticipated further reduction of certain loans, and the funding provided for the acquisition of the Wrinkles Schminkles business. The projections also presume that the loans, which are currently due for repayment on 31 December 2026, will be extended at least to the end of the forecast period. Furthermore reasonably possible downside scenarios are also considered, including lower revenue and gross margins, delays in cash collection, increased input and operating costs, adverse movements in working capital and continued macroeconomic and tariff-related pressures. Management has identified mitigating actions that could be taken in response to such circumstances, including the continued management of operating costs, inventory purchasing and working capital, the rationalisation of brands and product lines, and further actions to improve the Group’s contribution margins and cash generation.NorthWall Capital has provided a letter of support to the Company. However, there is no legal obligation on NorthWall Capital to provide additional funding or other financial support, including extending the loans beyond 31 December 2026, to the Company or the Group beyond amounts that have been formally committed. The availability, timing and amount of any additional support remain at the discretion of NorthWall Capital. Accordingly, the letter of support, capital contributions, loan waivers and other financial support provided to date do not represent a legally enforceable commitment to provide all further funding that the Company or the Group may require throughout the going concern assessment period. If the anticipated funding is not available, alternative sources of funding would be required.After considering the forecasts and cash flow projections, the significant capital injection received, the waiver and planned further reduction of certain loans, the financial support provided since the restructuring and the mitigating actions available, the directors have a reasonable expectation that the Company and the Group have adequate resources to continue in operational existence for the foreseeable future. The directors therefore continue to adopt the going concern basis of accounting in preparing these financial statements.However, the Company and the Group remain dependent upon continued capital contributions and financial support including extending the loans beyond 31 December 2026, during the going concern assessment period. The requirement for further financial support, together with the absence of a legally enforceable obligation requiring NorthWall Capital to provide all additional funding that may be required, and to extend the loans, indicates that a material uncertainty exists which may cast significant doubt upon the Company’s and the Group’s ability to continue as going concerns and, therefore, their ability to realise their assets and discharge their liabilities in the normal course of business.The financial statements do not include any adjustments that would be necessary if the Company or the Group were unable to continue as going concerns. 2157903479595021579034795950659475106116179062572100322910515842601061746706872332888226698721608133246461178650429233414588144152396454103252631511258039777109570554543834935512114291635708235301141604918400933498291660642105144035182645731300485243873621435012326241013824862375297075043796871231688569513772323721975151913344964924815191334496492481001548125844725994447259944472599444725994447259944472599416234832162348321623483210043972420100439724204397232027788375277883752778837527788375100161840451618394510016184045161839452 October 2026154811584397232059438313360709930522137470994877147127648403361393863901004612957GuildfordOur objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: We obtained a general understanding of the Group’s legal and regulatory framework through enquiry of management concerning their understanding of relevant laws and regulations in the countries in which the group operates, the entity’s policies and procedures regarding compliance, and how they identify, evaluate and account for litigation claims. We also drew on our existing understanding of the group’s industry and regulation. We understand that the group complies with the framework through: Updating operating procedures, manuals and internal controls as legal and regulatory requirements changeClose liaison with suppliers as regards product safety testing and conformity markingInspection of products for quality prior to shipment from the producing countryThe Directors’ close involvement in the day-to-day running of the business, meaning that any litigation or claims would come to their attention directlyTaking necessary action in the event of any regulatory concernsOutsourcing payroll and tax compliance to external experts. In the context of the audit, we considered those laws and regulations which determine the form and content of the financial statements, which are central to the group’s ability to conduct its business, and/or where there is a risk that failure to comply could result in material penalties. We identified the following laws and regulations as being of significance in the context of the group: The Companies Act 2006 and FRS 102 in respect of the preparation and presentation of the financial statements.Consumer laws relevant to the health, safety and environmental requirements of the group’s products. We performed the following specific procedures to gain evidence about compliance with the significant laws and regulations identified above: Enquiries of management including review of relevant correspondence;Obtaining written management representations regarding the adequacy of procedures in place. The senior statutory auditor led a discussion with senior members of the engagement team regarding the susceptibility of the entity’s financial statements to material misstatement, including how fraud might occur. The areas identified in this discussion were: Manipulation of the financial statements through incorrect estimation relating to potential impairments of intangible fixed assetsIncorrect revenue recognition including errors in the assessment of possible returns after the end of the accounting periodThe appropriateness of the going concern assessmentThe accuracy and classification of exceptional gains arising from:The liquidation of the Bakblade trading entityThe Group restructure which resulted in the cancellation of the balance due to the parent company and the change in ownershipThe partial forgiveness of debt by the lenderThe accuracy of stock quantities and stock costThe cost of stock soldThe accuracy of the balance due to the lenderManipulation of the financial statements via fraudulent journal entries These areas were communicated to the other members of the engagement team not present at the discussion. The procedures we carried out to gain evidence in the above areas included: In respect of the estimates identified above:Challenging management regarding the methodology used in making the estimates identified above and their judgements and assumptionsComparisons with market data and post-year-end data as appropriateSubstantive work on revenue, including the assessment of returns provisionsReview of the Group’s forecasts used to support their going concern assessment, including comparisons with post-year-end data and sensitivity analysis; communication with the lenderReview of the legal agreements giving rise to the exceptional gains and the Company’s accounting assessments; agreement of the gains to underlying accounting records and other evidence; assessment of the classification by reference to UK GAAP and best practiceSubstantive work on stock costs and quantities; assessment of the accounting and control systems implemented by the Group over stock purchases, stock holding and stock movementsSubstantive work on cost of stock sold in the year, including assessing the reliability of the supporting evidenceObtaining third party confirmation of the balances due to the lenderTesting of a sample of manual journal entries, selected through applying specific risk assessments based on the Group's processes and controls surrounding manual journal entries. A further description of our responsibilities is available on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.2 October 202631 December 2024Olsam Opco LimitedFinancials UK FRS 1022026.8.2+94963283,243669,73643972320154811581145104732860377916234832 13065587 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2023-12-31 13065587 bus:Director2 2024-12-31 13065587 bus:Director1 2024-12-31 13065587 1 2024-01-01 2024-12-31 13065587 core:ComputerEquipment 2023-12-31 13065587 bus:Director4 2024-12-31 13065587 core:ComputerEquipment 2024-12-31 13065587 bus:Audited 2024-01-01 2024-12-31 13065587 core:Subsidiary7 2024-01-01 2024-12-31 13065587 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 13065587 bus:Director10 2024-01-01 2024-12-31 13065587 core:Subsidiary8 2024-01-01 2024-12-31 13065587 core:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 13065587 core:Subsidiary17 2024-01-01 2024-12-31 13065587 core:Subsidiary16 2024-01-01 2024-12-31 13065587 core:Subsidiary18 2024-01-01 2024-12-31 13065587 core:Subsidiary14 2024-01-01 2024-12-31 13065587 bus:OrdinaryShareClass1 2024-12-31 13065587 core:RetainedEarningsAccumulatedLosses 2024-12-31 13065587 core:RetainedEarningsAccumulatedLosses 2023-12-31 13065587 core:CopyrightsPatentsTrademarksServiceOperatingRights 2024-01-01 2024-12-31 13065587 6 2024-01-01 2024-12-31 13065587 core:Subsidiary8 1 2024-01-01 2024-12-31 13065587 core:Subsidiary9 2024-01-01 2024-12-31 13065587 bus:Director2 2024-01-01 2024-12-31 13065587 core:OtherCapitalReserve 1 2024-01-01 2024-12-31 13065587 core:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 13065587 core:ShareCapital 2023-12-31 13065587 4 2024-01-01 2024-12-31 13065587 core:RetainedEarningsAccumulatedLosses 2023-01-01 13065587 core:WithinOneYear 2023-12-31 13065587 core:Subsidiary20 2024-01-01 2024-12-31 13065587 bus:Director1 2024-01-01 2024-12-31 13065587 core:OtherCapitalReserve 2024-01-01 2024-12-31 13065587 core:Subsidiary13 1 2024-01-01 2024-12-31 13065587 core:Subsidiary2 2024-01-01 2024-12-31 13065587 core:Subsidiary4 1 2024-01-01 2024-12-31 13065587 1 2024-01-01 2024-12-31 13065587 core:Subsidiary9 1 2024-01-01 2024-12-31 13065587 core:Subsidiary2 1 2024-01-01 2024-12-31 13065587 2 2024-01-01 2024-12-31 13065587 core:CopyrightsPatentsTrademarksServiceOperatingRights 2024-12-31 13065587 5 2024-01-01 2024-12-31 13065587 bus:Director3 2024-12-31 13065587 core:ShareCapital 2024-12-31 13065587 core:PreviouslyStatedAmount 2023-12-31 13065587 core:Subsidiary18 1 2024-01-01 2024-12-31 13065587 bus:Director4 2024-01-01 2024-12-31 13065587 core:CurrentFinancialInstruments 2024-12-31 13065587 core:Subsidiary11 1 2024-01-01 2024-12-31 13065587 core:Subsidiary6 1 2024-01-01 2024-12-31 13065587 core:Subsidiary5 2024-01-01 2024-12-31 13065587 core:Goodwill 2024-01-01 2024-12-31 13065587 core:PreviouslyStatedAmount 2023-01-01 13065587 core:Subsidiary16 1 2024-01-01 2024-12-31 13065587 core:ComputerEquipment 2024-01-01 2024-12-31 13065587 core:Subsidiary1 2024-01-01 2024-12-31 13065587 core:Subsidiary1 1 2024-01-01 2024-12-31 13065587 bus:Director3 2024-01-01 2024-12-31 13065587 bus:RegisteredOffice 2024-01-01 2024-12-31 13065587 core:ShareCapital 2023-01-01 13065587 core:InvestmentPropertiesRevaluationReserve 2024-01-01 2024-12-31 13065587 bus:FullAccounts 2024-01-01 2024-12-31 13065587 curr:PoundSterling 2024-01-01 2024-12-31 13065587 core:CopyrightsPatentsTrademarksServiceOperatingRights 2023-12-31 13065587 core:Non-currentFinancialInstruments 2023-12-31 13065587 bus:OrdinaryShareClass1 2023-12-31 13065587 3 2024-01-01 2024-12-31 13065587 bus:Director10 2024-12-31 13065587 core:Subsidiary7 1 2024-01-01 2024-12-31 13065587 core:Subsidiary10 2024-01-01 2024-12-31 13065587 8 2024-01-01 2024-12-31 13065587 core:Subsidiary19 2024-01-01 2024-12-31 13065587 6 2024-01-01 2024-12-31 13065587 6 2023-01-01 2023-12-31 13065587 core:Subsidiary19 1 2024-01-01 2024-12-31 13065587 3 2023-01-01 2023-12-31 13065587 core:Subsidiary5 1 2024-01-01 2024-12-31 13065587 bus:Director6 2024-12-31 13065587 core:Subsidiary13 2024-01-01 2024-12-31 13065587 core:Subsidiary14 1 2024-01-01 2024-12-31 13065587 7 2023-01-01 2023-12-31 13065587 core:Subsidiary20 1 2024-01-01 2024-12-31 13065587 8 2023-01-01 2023-12-31 13065587 bus:Director5 2024-12-31 13065587 2024-01-01 13065587 2 2023-01-01 2023-12-31 13065587 core:CurrentFinancialInstruments 2023-12-31 13065587 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 13065587 core:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 13065587 bus:Director6 2024-01-01 2024-12-31 13065587 core:Non-currentFinancialInstruments 2024-12-31 13065587 core:ComputerSoftware 2024-12-31 13065587 core:Subsidiary3 2024-01-01 2024-12-31 13065587 bus:Director5 2024-01-01 2024-12-31 13065587 core:ComputerSoftware 2024-01-01 2024-12-31 13065587 core:ShareCapital core:PreviouslyStatedAmount 2023-01-01 13065587 core:Subsidiary15 2024-01-01 2024-12-31 13065587 core:Subsidiary3 1 2024-01-01 2024-12-31 13065587 core:Subsidiary4 2024-01-01 2024-12-31 13065587 core:Subsidiary12 1 2024-01-01 2024-12-31 13065587 core:OwnedOrFreeholdAssets core:ComputerEquipment 2024-01-01 2024-12-31 13065587 1 2024-01-01 2024-12-31 13065587 core:Subsidiary10 1 2024-01-01 2024-12-31 13065587 core:ComputerSoftware 2023-12-31 13065587 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2023-01-01 13065587 core:Subsidiary15 1 2024-01-01 2024-12-31 13065587 core:WithinOneYear 2024-12-31 13065587 bus:FRS102 2024-01-01 2024-12-31 13065587 1 2023-01-01 2023-12-31 13065587 core:ShareCapital core:PreviouslyStatedAmount 2023-12-31 13065587 core:RetainedEarningsAccumulatedLosses 1 2024-01-01 2024-12-31 13065587 core:Subsidiary12 2024-01-01 2024-12-31 13065587 core:Subsidiary11 2024-01-01 2024-12-31 13065587 core:Subsidiary17 1 2024-01-01 2024-12-31 13065587 core:Subsidiary6 2024-01-01 2024-12-31 13065587 2023-12-31 13065587 2024-12-31 13065587 2023-01-01 2023-12-31 13065587 core:ContinuingOperations 2023-01-01 2023-12-31 13065587 2024-01-01 2024-12-31 13065587 core:ContinuingOperations 2024-01-01 2024-12-31 13065587 2023-01-01 xbrli:pure iso4217:GBP xbrli:shares xbrli:pure xbrli:shares iso4217:GBP iso4217:GBP